COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
Osteoarthritis (OA) is among challenging problems of clinical medicine, not only due to its high prevalence, but also because of higher burden of comorbidities. Previously we described a clinical phenotype of OA associated with type 2 diabetes mellitus (OADM), which is one of OA phenotypes character...
Guardado en:
Autores principales: | I. V. Shirinsky, O. V. Sazonova, N. Yu. Kalinovskaya, V. S. Shirinsky |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c83b7bb79ab64611b8952c6f4d570f0a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2016) -
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2015) -
Combination treatment of patients with metabolic phenotype of osteoarthritis: an exploratory study
por: V. S. Shirinsky, et al.
Publicado: (2020) -
DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
por: E. V. Kazygasheva, et al.
Publicado: (2016) -
Clinical and immunological features of metabolic phenotype of osteoarthritis
por: V. S. Shirinsky, et al.
Publicado: (2020)